Advertisement
Home Blog Page 1365

March 2020 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for March 2020. This roundup includes the...

March 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for March 2020. This roundup includes...

March 2020 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for March 2020. This roundup includes the latest...

March 2020 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for March 2020. This roundup includes the...

March 2020 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for March 2020. This roundup includes...

March 2020 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for March 2020. This roundup includes the latest...

March 2020 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for March 2020. This roundup includes the latest...

March 2020 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for March 2020. This roundup includes the latest...
About one-third of patients with coronavirus disease 2019 have ocular abnormalities

Ocular Abnormalities Seen in One-Third of COVID-19 Patients

Patients with ocular symptoms more likely to have higher white blood cell count, neutrophil count
Liraglutide plus lifestyle therapy results in a significantly greater reduction in body mass index standard-deviation score than placebo among adolescents with obesity

ENDO: Liraglutide May Benefit Adolescents With Obesity

Reduction in BMI standard-deviation score greater for liraglutide + lifestyle therapy versus placebo